743 related articles for article (PubMed ID: 20060750)
1. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
4. Comparison between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labeling techniques in distinguishing malignant from benign brain tumors.
Ata ES; Turgut M; Eraslan C; Dayanır YÖ
Eur J Radiol; 2016 Sep; 85(9):1545-53. PubMed ID: 27501887
[TBL] [Abstract][Full Text] [Related]
5. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
[TBL] [Abstract][Full Text] [Related]
7. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
9. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
[TBL] [Abstract][Full Text] [Related]
13. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
14. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
15. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas.
Reddy K; Westerly D; Chen C
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):349-55. PubMed ID: 23721146
[TBL] [Abstract][Full Text] [Related]
16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
17. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
Yen RF; Hung RL; Pan MH; Wang YH; Huang KM; Lui LT; Kao CH
Cancer; 2003 Jul; 98(2):283-7. PubMed ID: 12872346
[TBL] [Abstract][Full Text] [Related]
18. Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.
Thiel A; Pietrzyk U; Sturm V; Herholz K; Hövels M; Schröder R
Neurosurgery; 2000 Jan; 46(1):232-4. PubMed ID: 10626957
[TBL] [Abstract][Full Text] [Related]
19. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
[TBL] [Abstract][Full Text] [Related]
20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
